Bay Harbor Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bay Harbor Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.37K	Buy	14 +1	+8%	+$219	﹤0.01%	519
2026 Q1	$2.46K	Buy	13 +6	+86%	+$1.05K	﹤0.01%	512
2025 Q4	$1.19K	Buy	7 +2	+40%	+$307	﹤0.01%	594
2025 Q3	$659	Buy	5 +1	+25%	+$120	﹤0.01%	629
2025 Q2	$424	Buy	4 +2	+100%	+$217	﹤0.01%	697
2025 Q1	$248	Buy	+2	New	+$261	﹤0.01%	607

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bay Harbor Wealth Management's JAZZ Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 7.7% in Q2 2026, buying an estimated $219 and bringing the position to 14 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Bay Harbor Wealth Management first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Bay Harbor Wealth Management held 14 shares of Jazz Pharmaceuticals worth $3.37K as of Q2 2026.
Bay Harbor Wealth Management bought 1 Jazz Pharmaceuticals share in Q2 2026, an estimated $219.
Jazz Pharmaceuticals made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #519 holding.
Bay Harbor Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.